Pharmacogenetics: ethnicity, treatment and health in Latin American populations

Martha Sosa-Macías; Ingrid Fricke-Galindo; Humberto Fariñas; Lucero Monterde; Eugenia Dolores Ruiz-Cruz; Juan Molina-Guarneros; Eduardo Tarazona-Santos; Fernanda Rodrigues-Soares; Carlos Galaviz-Hernández; Eva Peñas-Lledó; Graciela Moya; Julio Lara-Riegos; Enrique Terán; Isabel Hernández; Ronald Ramírez-Roa; Catalina Altamirano-Tinoco; Marisol López-López; José Elías García-Ortiz; Adrián Llerena

doi:10.2217/pgs-2023-0098

Pharmacogenetics: ethnicity, treatment and health in Latin American populations

Martha Sosa-Macías
, Ingrid Fricke-Galindo
, Humberto Fariñas
, Lucero Monterde
, Eugenia Dolores Ruiz-Cruz
, Juan Molina-Guarneros
, Eduardo Tarazona-Santos
, Fernanda Rodrigues-Soares
, Carlos Galaviz-Hernández
, Eva Peñas-Lledó
, Graciela Moya
, Julio Lara-Riegos
, Enrique Terán
, Isabel Hernández
, Ronald Ramírez-Roa
, Catalina Altamirano-Tinoco
, Marisol López-López
, José Elías García-Ortiz
, Adrián Llerena^*

^*Autor correspondiente de este trabajo

RIBEF Ibero American Network of Pharmacogenetics & Pharmacogenomics
IPN
Natl. Inst. of Respiratory Diseases
University of Extremadura
SIFF Ibero American Society of Pharmacogenetics & Pharmacogenomics
Mexican Association of Human Genetic
Instituto Mexicano del Seguro Social
Universidad Nacional Autónoma de México
Universidade Federal de Minas Gerais
Universidad Peruana Cayetano Heredia
Universidade Federal do Triângulo Mineiro
Pontificia Universidad Católica Argentina Santa María de los Buenos Aires - UCA
Universidad Autónoma de Yucatán
Pontificia Universidad Católica del Ecuador
Universidad Nacional Autónoma de Nicaragua
Universidad Autónoma Metropolitana
Centro de Investigación Biomédica de Occidente
RELAGH Latin American Network of Human Genetics

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

9 Citas (Scopus)

Resumen

The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of Mérida/T'Hó and the call for the Dr José María Cantú Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.

Idioma original	Inglés
Páginas (desde-hasta)	489-492
Número de páginas	4
Publicación	Pharmacogenomics
Volumen	24
N.º	9
DOI	https://doi.org/10.2217/pgs-2023-0098
Estado	Publicada - 1 jun. 2023

Acceder al documento

10.2217/pgs-2023-0098

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

Sosa-Macías, M., Fricke-Galindo, I., Fariñas, H., Monterde, L., Ruiz-Cruz, E. D., Molina-Guarneros, J., Tarazona-Santos, E., Rodrigues-Soares, F., Galaviz-Hernández, C., Peñas-Lledó, E., Moya, G., Lara-Riegos, J., Terán, E., Hernández, I., Ramírez-Roa, R., Altamirano-Tinoco, C., López-López, M., García-Ortiz, J. E., & Llerena, A. (2023). Pharmacogenetics: ethnicity, treatment and health in Latin American populations. Pharmacogenomics, 24(9), 489-492. https://doi.org/10.2217/pgs-2023-0098

@article{e775389985d741f4b017f2a1c1da46ae,

title = "Pharmacogenetics: ethnicity, treatment and health in Latin American populations",

abstract = "The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of M{\'e}rida/T'H{\'o} and the call for the Dr Jos{\'e} Mar{\'i}a Cant{\'u} Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.",

keywords = "Latin American, Native Americans, biomarkers, ethnicity, pharmacogenetics",

author = "Martha Sosa-Mac{\'i}as and Ingrid Fricke-Galindo and Humberto Fari{\~n}as and Lucero Monterde and Ruiz-Cruz, \{Eugenia Dolores\} and Juan Molina-Guarneros and Eduardo Tarazona-Santos and Fernanda Rodrigues-Soares and Carlos Galaviz-Hern{\'a}ndez and Eva Pe{\~n}as-Lled{\'o} and Graciela Moya and Julio Lara-Riegos and Enrique Ter{\'a}n and Isabel Hern{\'a}ndez and Ronald Ram{\'i}rez-Roa and Catalina Altamirano-Tinoco and Marisol L{\'o}pez-L{\'o}pez and Garc{\'i}a-Ortiz, \{Jos{\'e} El{\'i}as\} and Adri{\'a}n Llerena",

note = "Publisher Copyright: {\textcopyright} 2023 Future Medicine Ltd.",

year = "2023",

month = jun,

day = "1",

doi = "10.2217/pgs-2023-0098",

language = "Ingl{\'e}s",

volume = "24",

pages = "489--492",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor and Francis Ltd.",

number = "9",

}

Sosa-Macías, M, Fricke-Galindo, I, Fariñas, H, Monterde, L, Ruiz-Cruz, ED, Molina-Guarneros, J, Tarazona-Santos, E, Rodrigues-Soares, F, Galaviz-Hernández, C, Peñas-Lledó, E, Moya, G, Lara-Riegos, J, Terán, E, Hernández, I, Ramírez-Roa, R, Altamirano-Tinoco, C, López-López, M, García-Ortiz, JE & Llerena, A 2023, 'Pharmacogenetics: ethnicity, treatment and health in Latin American populations', Pharmacogenomics, vol. 24, n.º 9, pp. 489-492. https://doi.org/10.2217/pgs-2023-0098

TY - JOUR

T1 - Pharmacogenetics

T2 - ethnicity, treatment and health in Latin American populations

AU - Sosa-Macías, Martha

AU - Fricke-Galindo, Ingrid

AU - Fariñas, Humberto

AU - Monterde, Lucero

AU - Ruiz-Cruz, Eugenia Dolores

AU - Molina-Guarneros, Juan

AU - Tarazona-Santos, Eduardo

AU - Rodrigues-Soares, Fernanda

AU - Galaviz-Hernández, Carlos

AU - Peñas-Lledó, Eva

AU - Moya, Graciela

AU - Lara-Riegos, Julio

AU - Terán, Enrique

AU - Hernández, Isabel

AU - Ramírez-Roa, Ronald

AU - Altamirano-Tinoco, Catalina

AU - López-López, Marisol

AU - García-Ortiz, José Elías

AU - Llerena, Adrián

PY - 2023/6/1

Y1 - 2023/6/1

N2 - The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of Mérida/T'Hó and the call for the Dr José María Cantú Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.

AB - The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of Mérida/T'Hó and the call for the Dr José María Cantú Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.

KW - Latin American

KW - Native Americans

KW - biomarkers

KW - ethnicity

KW - pharmacogenetics

UR - https://www.scopus.com/pages/publications/85168222657

U2 - 10.2217/pgs-2023-0098

DO - 10.2217/pgs-2023-0098

M3 - Artículo

C2 - 37529900

AN - SCOPUS:85168222657

SN - 1462-2416

VL - 24

SP - 489

EP - 492

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 9

ER -

Pharmacogenetics: ethnicity, treatment and health in Latin American populations

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto